Show simple item record

dc.contributor.advisorCoates, Dawn
dc.contributor.advisorRich, Alison
dc.contributor.authorGreer, Philippa
dc.date.available2018-11-04T22:02:56Z
dc.date.copyright2018
dc.identifier.citationGreer, P. (2018). Effects of OTX008, a galectin-1 inhibitor, on oral squamous cell carcinoma cells in vitro (Thesis, Doctor of Clinical Dentistry). University of Otago. Retrieved from http://hdl.handle.net/10523/8529en
dc.identifier.urihttp://hdl.handle.net/10523/8529
dc.description.abstractOral squamous cell carcinoma (OSCC) is a common cancer that is currently associated with significant morbidity and poor mortality, and for which targeted therapeutics have yet to be proved effective. Galectin-1 is a carbohydrate-binding protein that is commonly upregulated in cancers and is associated with increased risks of metastases, promotion of angiogenesis and escape of the immune response. Galectin-1 has been shown to be upregulated in OSCC, and this upregulation is associated with increased invasion and poor prognosis. The aim of this study was to assess whether the small molecule galectin-1 inhibitor, OTX008, could inhibit OSCC cells in vitro, and to investigate how OTX008 affects the expression of a narrow array of genes in OSCC. One normal oral keratinocyte (NOK) cell line and three OSCC cell lines were cultured and the expression of galectin-1 protein in each quantified using an ELISA. All cell lines were found to express galectin-1, and one of the OSCC lines produced significantly more galectin-1 than the NOK cell line at 6, 24 and 48 hours. Quantification of galectin-1 mRNA expression in each cell line confirmed these results. All four cell lines were cultured with three concentrations of galectin-1 (50, 100 and 150 ng/mL) and four concentrations of OTX008 (12.5, 25, 50 and 100 μg/mL), and cell viability was assayed at 24, 48, 72 and 96 hours. Galectin-1 decreased cell viability at 24 hours in two of the OSCC lines, had no effect on the third, and increased cell viability in the NOK cells at 72 hours. OTX008 reduced cell viability in a dose-dependent manner in all cell lines, and this effect increased at each time point during a 96 hour culture period. OTX008 had the greatest effect on cell viability of the OSCC line with the highest galectin-1 levels compared to the other cell lines. Gene expression in OSCC cells following 48 hours of treatment with 25 μg of OTX008 was relatively unaffected, with the exception of expression of c-Fos which was significantly elevated in two of the OSCC cell lines. The results of this study suggest that OTX008 may have therapeutic potential in the treatment of OSCC, possibly through induction of apoptosis via the AP-1 pathway.
dc.language.isoen
dc.publisherUniversity of Otago
dc.rightsAll items in OUR Archive are provided for private study and research purposes and are protected by copyright with all rights reserved unless otherwise indicated.
dc.subjectoral
dc.subjectsquamous
dc.subjectcell
dc.subjectcarcinoma
dc.subjectcancer
dc.subjectgalectin-1
dc.subjectOTX008
dc.titleEffects of OTX008, a galectin-1 inhibitor, on oral squamous cell carcinoma cells in vitro
dc.typeThesis
dc.date.updated2018-11-04T20:35:36Z
dc.language.rfc3066en
thesis.degree.disciplineSir John Walsh research Institute
thesis.degree.nameDoctor of Clinical Dentistry
thesis.degree.grantorUniversity of Otago
thesis.degree.levelDoctoral
otago.interloanyes
otago.openaccessAbstract Only
 Find in your library

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item is not available in full-text via OUR Archive.

If you would like to read this item, please apply for an inter-library loan from the University of Otago via your local library.

If you are the author of this item, please contact us if you wish to discuss making the full text publicly available.

This item appears in the following Collection(s)

Show simple item record